Injective Opens Pre-IPO Market for Anthropic Ahead of Nasdaq Listing

Injective has launched a pre-IPO market for Anthropic, giving investors on-chain exposure to the AI company's equity before its planned Nasdaq debut. The market opened ahead of an expected IPO date of November 19, 2026, according to Injective's market data.

Anthropic plans to offer 825 million shares priced between $70 and $78, a range that implies a valuation between $1.25 trillion and $1.45 trillion. The company was last valued privately at approximately $965 billion, meaning the proposed listing range would mark a step up of roughly 30% from that prior mark.

The pricing activity on Injective already reflects firm expectations about timing and scale. Traders put a 93.3% probability on the IPO pricing on November 19, while earlier dates show negligible support, according to the platform's market data. On valuation, participants assign a 43.5% chance that Anthropic closes its first trading day with a market capitalization between $1.25 trillion and $1.5 trillion — a band that straddles the upper end of the proposed range.

What does the pre-IPO market change?

The launch extends Injective's venue into a category traditionally reserved for private-placement desks and secondary platforms: equity exposure to a company that has not yet cleared its registration process. For Injective, listing a pre-IPO contract on a trillion-dollar candidate signals confidence in both the deal's timing and its valuation range, as evidenced by the market's pricing and early activity.

For market participants, the product offers a way to express a view on the IPO before the shares trade on Nasdaq. The current pricing effectively treats the November 19 date as settled: the 93.3% YES figure leaves little room for an accelerated or delayed debut.

The listing also functions as an early read on sentiment toward AI-sector equities. Anthropic's offering is expected to test public appetite for AI investments at a valuation scale the public markets have not previously absorbed for a first-time listing — the jump from a $965 billion private mark toward a $1.25 trillion-plus public one.

What happens next?

Several checkpoints sit between now and the debut. The SEC's review of Anthropic's registration statement could confirm or push back the November 19 date. Underwriter reports and any adjustments to the pricing range or deal size — the current band of $70 to $78 per share and 825 million shares remain the reference figures — would move both the pre-IPO market and expected sentiment.

Broader AI-sector developments and market conditions also remain variables for the valuation, Injective noted in its market commentary.

The practical deadline is the registration review: SEC sign-off on the filing would lock in the timeline the pre-IPO market has already priced at 93.3%. Until then, the on-chain contract serves as the earliest continuous gauge of institutional and retail expectations for one of the largest listings on record.